Gergely J
Debreceni Orvostudományi Egyetem Gyógyszertani Intézete.
Acta Pharm Hung. 1998 Jul;68(4):205-9.
To study side effects of drugs in preclinical as well as in postmarketing surveillance phase is very important. In our experiments the influence of metoprolol on carbohydrate- and lipid metabolism was investigated in male. Wistar rats. Metoprolol is a liposoluble beta1-selective adrenoceptor antagonists. We have calculated therapeutic dose which reduced heart frequency/min of the animals by 25%. This was 10 mg/kg. The blood glucose and triglyceride values of healthy rats are in the normal human domain. Blood glucose was high after the first metoprolol dose and increased further with continued treatment. Drug administration period comprised 16 days. At finishing experiments diminished glycogen content was measured which may be related to higher glucose output. In blood samples obtained one hour after last 16. metoprolol dose administration triglyceride values were high and HDL-C decreased. These data pertain to the development of a secondary hypertriglyceridaemia. Hyperglycemic and hypertriglyceridaemic responses were established with therapeutic doses regimen so they may be considered as unwanted effects.
研究药物在临床前以及上市后监测阶段的副作用非常重要。在我们的实验中,研究了美托洛尔对雄性Wistar大鼠碳水化合物和脂质代谢的影响。美托洛尔是一种脂溶性β1选择性肾上腺素能受体拮抗剂。我们计算出使动物心率/分钟降低25%的治疗剂量,为10毫克/千克。健康大鼠的血糖和甘油三酯值处于正常人类范围。首次给予美托洛尔剂量后血糖升高,并随着持续治疗进一步升高。给药期为16天。实验结束时测量到糖原含量减少,这可能与较高的葡萄糖输出有关。在最后一次给予美托洛尔剂量1小时后采集的血样中,甘油三酯值升高,高密度脂蛋白胆固醇降低。这些数据与继发性高甘油三酯血症的发生有关。在治疗剂量方案下出现了高血糖和高甘油三酯反应,因此可将其视为不良反应。